Increasing prevalence of cystic fibrosis, and rising need for treatments to reduce burden of disease are key factors driving market revenue growth.
Market Size - USD 6.49 Billion in 2020, Market Growth - CAGR of 16.8%, Market Trends - Rising investments by major players in research and development of advanced and novel drugs.
The global cystic fibrosis drug market size is expected to reach USD 22.41 Billion in 2028, and register a CAGR of 16.8% during the forecast period. Rising awareness regarding identified mutations and need for constant research and development of treatment and drugs is a major factor constantly driving growth of the global cystic fibrosis drug market. At present, there are around 1900 identified CFTR mutations that are responsible for cystic fibrosis diseases and treatments have been found for only about half of the mutations.
Cystic fibrosis, also known as mucoviscidosis, is a genetic disorder, which generally affects the lungs, but also the pancreas, liver, kidneys, and intestine.
However, high cost of cystic fibrosis drugs is a major factor that could hamper its adoption rate and restrain growth of the global cystic fibrosis drug market.
Some Key Findings From the Report:
For the purpose of this report, the global cystic fibrosis drug market is segmented on the basis of drug type, drug administration, application, and region:
Drug Type Outlook
Drug Administration Outlook
Application Outlook
Region Outlook
Reasons to Buy the Report
Market Size - USD 6.49 Billion in 2020, Market Growth - CAGR of 16.8%, Market Trends - Rising investments by major players in research and development of advanced and novel drugs.
The global cystic fibrosis drug market size is expected to reach USD 22.41 Billion in 2028, and register a CAGR of 16.8% during the forecast period. Rising awareness regarding identified mutations and need for constant research and development of treatment and drugs is a major factor constantly driving growth of the global cystic fibrosis drug market. At present, there are around 1900 identified CFTR mutations that are responsible for cystic fibrosis diseases and treatments have been found for only about half of the mutations.
Cystic fibrosis, also known as mucoviscidosis, is a genetic disorder, which generally affects the lungs, but also the pancreas, liver, kidneys, and intestine.
However, high cost of cystic fibrosis drugs is a major factor that could hamper its adoption rate and restrain growth of the global cystic fibrosis drug market.
Some Key Findings From the Report:
- Among the drug administration segments, the oral segment accounted for the largest revenue share of 71.4% in 2020.
- North America cystic fibrosis drug market is expected to dominate in the global market over the forecast period, due to increasing spending on personal health and wellness, well-developed healthcare sector, various initiatives and projects undertaken by non-profit organizations, and strong presence of several major players including Vertex Pharmaceuticals.
- The Asia Pacific market was valued at USD 1.80 Billion in 2020, and is expected to register the highest revenue growth rate during the forecast period.
- Key players profiled in the report include Vertex Pharmaceuticals, F.Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, Allergan, Chiesi Farmaceutici S.p.A., Actavis, Arcturus Therapeutics, Boehringer Ingelheim, Genzyme, Insmed, Pharmaxis, Proteostasis Therapeutics, and Venus Remedies. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
For the purpose of this report, the global cystic fibrosis drug market is segmented on the basis of drug type, drug administration, application, and region:
Drug Type Outlook
- Pancreatic Enzyme Supplements
- Multivitamins
- Mucolytics
- Antibiotics
- Bronchodilators
- Anti-Inflammatory Agents
- CFTR Potentiators
- Others
Drug Administration Outlook
- Oral
- Injection
Application Outlook
- Hospitals
- Clinics
- Others
Region Outlook
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
Reasons to Buy the Report
- A robust analysis and estimation of the Cystic Fibrosis Drug Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
- A holistic competitive landscape of the all the major players in the Cystic Fibrosis Drug Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
- Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
- Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
- Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Table of Contents
1 Cystic Fibrosis Drugs Market Overview
2 Global Cystic Fibrosis Drugs Market Competition by Manufacturers
3 Global Cystic Fibrosis Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
4 Global Cystic Fibrosis Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
5 Global Cystic Fibrosis Drugs Production, Revenue (Value), Price Trend by Type
6 Global Cystic Fibrosis Drugs Market Analysis by Application
7 Global Cystic Fibrosis Drugs Manufacturers Profiles/Analysis
8 Cystic Fibrosis Drugs Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Cystic Fibrosis Drugs Market Forecast (2017-2022)
14 Appendix
